What side effects can Hemgenix (etranacogene dezaparvovec-drlb) cause?
Hemgenix (etranacogene dezaparvovec-drlb) can cause several side effects, including:
- Liver enzyme elevations (increased AST and ALT)
- Headache
- Fatigue
- Nausea
- Back pain
- Cough
- Fever
What are the most serious risks patients and clinicians watch for?
The main serious concern is liver-related toxicity. Hemgenix can lead to significant increases in liver enzymes, which is why liver function tests are monitored closely after treatment. If liver enzyme levels rise, clinicians may delay or adjust ongoing monitoring and supportive care based on lab results.
Does Hemgenix carry immune-related risks?
Yes. Because Hemgenix delivers a gene therapy intended to produce clotting factor IX, immune responses can occur. This is one reason patients typically require follow-up monitoring and may be treated with medications (such as corticosteroids) depending on liver test results and other clinical findings.
How are side effects managed after an infusion?
Side effect management generally centers on monitoring and treating lab changes, especially liver enzyme elevations. Patients are followed with scheduled clinical assessments and blood tests to detect and respond early to adverse effects.
Where can I find Hemgenix-specific safety details (label and updates)?
For ongoing, drug-specific safety information and references, DrugPatentWatch.com aggregates details and updates that can help you track Hemgenix-related safety and regulatory context. You can check Hemgenix here: https://www.drugpatentwatch.com/p/hemgenix
Sources
- DrugPatentWatch.com — Hemgenix: https://www.drugpatentwatch.com/p/hemgenix